Stop by at designated hot spots for a chance to win $300 cash prize drawn twice/day.... Learn More

− Company positioned for continued strong growth in domestic radioisotope production and radiopharmaceutical development to meet needs of pharmaceutical companies, radiopharmacies and patients – − NorthStar’s Mo-99 program continues at the forefront of U.S. radioisotope production as the only commercialized producer of key... Learn More

 May 30th, 2023 FOR IMMEDIATE RELEASE Media Contact: Jamie Smith Ameriflight, LLC Director of Corporate Communications jsmith@ameriflight.com | 972.426.3066 ext. 76273

Learn More

The U.S. Department of Energy Isotope Program is pleased to announce lead-203 (Pb-203) has been added to our catalog and is available for purchase. Pb-203 has drawn interest as a SPECT imaging isotope analogue to the therapeutic Pb-212, an alpha-emitter. Its addition to the NIDC Catalog establishes a theranostic matched pair... Learn More

Join us for the DOE Isotope Program Overview presentation and breakfast on Monday, June 26 at 7:00 a.m. in room E451a at McCormick Place.  The director of the Isotope Program, Dr. Jehanne Gillo, will present an overview of the program, discuss isotope availability, planned development efforts and how current world events are affecting isotope... Learn More

Berlin, Germany, 1 June 2023 – Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, is pleased to announce the acquisition of Theragnostics Ltd., a UK-based private biopharmaceutical company engaged in the development of radio-labelled PARP inhibitors for the diagnosis... Learn More

Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions, launches the latest version of its HERMIA Multimodality Viewing Software in Canada and in the USA. This new release of the Hermia Multimodality Viewer brings the next level of customization and personalization of... Learn More

VigTech Consulting is very proud of launching two great products in 2023.  The DDD Diagnostics CorCam Gamma Camera, one of the best dedicated Cardiac Gamma Camera in Canada. DDD Diagnostics, a leader in Gamma Camera designs is well-known Golden Standard in the Nuclear Cardiology.  CorCam... Learn More

Enhances TTG’s continued commitment to offer a full spectrum of high-quality and cost-effective service solutions in the cardiology and radiation oncology markets PITTSBURGH, PA (May 5, 2023) – TTG Imaging Solutions, LLC (TTG) announced today the acquisition of Digirad... Learn More

Fast Turnaround for 7m2 and 30m2 Freeze Dryers These two freeze dryers were meticulously engineered to adhere to FDA 21 CFR Part 11 and cGMP standards for both pilot and commercial batch production. As of now, the 7m2 unit is 70% mechanically complete, while the 30m unit is 40% mechanically complete.... Learn More

Dulles, VA –May 12, 2023 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, has dosed and imaged the first patient with [18F]FAPI-74 in its US Clinical Trial of flourine-18 labeled Fibroblast Activation Protein Inhibitor (FAPI). This study is a Phase 2, Multicenter, Non randomized Study of... Learn More

Ionetix completes commissioning of a 30 MeV cyclotron and produces Astatine-211. Lansing, MI, April 18, 2023 — Ionetix, a leading cyclotron technology innovator, isotope producer and radiopharmaceutical manufacturer, announced today the successful production of Astatine-211 at its new Alpha Isotope... Learn More

New Branding Initiatives Enhance Customer Engagement Mirion Technologies Has Rebranded to Mirion, Mirion Industrial is Now "Mirion Technologies" There is No Change in Mirion Medical Branding or Mirion’s Financial Reporting Methodology ATLANTA--(BUSINESS WIRE) -- Mirion (“we” or “the company”(NYSE: MIR), a... Learn More

ATLANTA--(BUSINESS WIRE)-- Mirion Technologies, Inc. (“Mirion,” “we” or the “Company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to... Learn More

Medical Business Units Join Together for Comprehensive & Complementary Clinical Solutions ATLANTA--(BUSINESS WIRE)-- Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”), today announced the rebranding of its Medical segment as the Mirion Medical group, comprised of the organization’s healthcare-focused Dosimetry Services, Sun Nuclear, CIRS, Biodex, and Capintec business units.... Learn More

ACIC Machinery is a leading provider of filling and sealing solutions ranging from small and large volume parenteral products to sterile and non-sterile filling. Applications include ampoules, vials, syringes, cartridges, glass/plastic bottles, and soft bags. These machines can process liquid, semi-solid, and powder products (freeze-dried). Let’s take a closer look at... Learn More

Automation in radiopharmaceutical manufacturing is a great thing for all stages of the supply chain. In the manufacturing of radiopharmaceuticals, for example, the automation process can prevent accidents caused by human error. But leakage of contaminants still happens due to various factors that can exist in the process. Precautions can... Learn More

Radiofrequency Welding Radiofrequency (RF) welding, also known as high-frequency welding, is an effective sealing process for the manufacture of medical bags such as ostomy bags, urine bags, and blood bags. Radiofrequency welding works through the simultaneous... Learn More

In recent years, there have been major advances in automation equipment for the manufacture of radiopharmaceuticals. Creating modern facilities that incorporate automated manufacturing processes improves product consistency, quality, and operator safety. Many radiopharmaceuticals are produced under aseptic conditions to ensure they meet all purity... Learn More

What is artificial intelligence?  Artificial intelligence (AI) involves using computers and software to do things that would traditionally require human intelligence. The difference? AI can consume and process large amounts of data. Levels of data and information that humans simply cannot process.  The goals... Learn More

New inspection machine for RTF container We are thrilled to announce the launch of our cutting-edge robotic visual inspection machine for Ready-To-Use (RTU) containers. This state-of-the-art system employs advanced camera technology and Artificial Intelligence (AI) to deliver precise inspections for particulate matter and... Learn More

Baltimore, Maryland – Rapid is pleased to announce that it has received FDA 510(k) market clearance for its first software product: 3D-RD-S, the first web-browser based application that implements the MIRD Schema to perform radiopharmaceutical dosimetry calculations. It is based on the most recent ICRP phantoms and data, supports 1,252... Learn More

Shielding NorthStar's first pair of IBA Rhodotron® accelerators - a first-of-its-kind radioisotope facility. June 27, 2022 11:00 ET | Source: Veritas Medical Solutions... HARLEYSVILLE, Pa., June 27, 2022 (GLOBE NEWSWIRE) -- As part of its expansion of radiation shielding solutions in the Industrial segment for radiopharmaceutical... Learn More

February 14th, 2023 FOR IMMEDIATE RELEASE Media Contact: Jamie Smith Ameriflight, LLC Director of Corporate Communications jsmith@ameriflight.com | 972.426.3066 ext. 76273

Learn More

January 26th, 2023 FOR IMMEDIATE RELEASE Media Contact: Jamie Smith Ameriflight, LLC Director of Corporate Communications jsmith@ameriflight.com | 972.426.3066 ext. 76273

Learn More

Saab 340B with digital rendering of Ameriflight livery

Learn More

https://www.youtube.com/watch?v=yUtfcOwfo1U ZTI BIOSCIENCES, Next Generation Radiopharmaceuticals Developer, wins the final award for U-CONNECT 2021 ... Learn More

https://www.youtube.com/watch?v=Sni8cyKkPo4 [MBN] ZTI BIOSCIENCES Targeted Radiopharmaceuticals: Next generation cancer therapy ZTI BIOSCIENCES was introduced at a national Korean economics broadcaster.  ... Learn More

https://www.youtube.com/watch?v=f_5k8QiHGWo YTN, an official major broadcaster in Korea had an exclusive interview with ZTI BIOSCIENCES, the national leader in radiopharmaceuticals. Dr. Jaden H. Chang, CEO of ZTI BIOSCIENCES explains the nature of Radio Ligand Therapy. CTO Dr. Eugene Park explains ZTI's basic tech.  ... Learn More

Plus Therapeutics Announces First Patient Dosed in ReSPECT-GBM Phase 2b Trial of Rhenium (186Re) Obisbemeda for Treatment of Recurrent Glioblastoma... Learn More

Plus Therapeutics Completes Enrollment in Second ReSPECT-LM Phase 1 Trial Cohort of Rhenium (¹⁸⁶Re) Obisbemeda for the Treatment of Leptomeningeal Metastases... Learn More

GenesisCare, Radiopharm Theranostics Partner to Bring World-First Novel Radiopharmaceuticals to Australian Cancer Patients